Skip to main content
. 2020 Sep 17;22(5):4151–4162. doi: 10.3892/mmr.2020.11521

Figure 2.

Figure 2.

Cumulative survival rates of rats post-treatment in each experimental group. CON, control; DOX, doxorubicin; Val, valsartan.